5-hydroxytryptamine



5-hydroxytryptamine

N 2 H N H O H

SMILES NCCc1c[nH]c2ccc(O)cc12
InChIKey QZAYGJVTTNCVMB-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 2
Hydrogen bond donors 3
Rotatable bonds 2
Molecular weight (Da) 176.1

Database connections

Structure pdb 7YS6 7XTB 7XT9 7XTA 7XT8 7E2Y 7WC4 7E32
Ligand site mutations 5-HT1A 5-HT1B 5-HT1D 5-HT2A 5-HT2B 5-HT2C 5-HT4 5-HT5A 5-HT6 5-HT7

Bioactivities

5-hydroxytryptamine

N 2 H N H O H

Drug properties

Molecular type Small molecule
Physiological/Surrogate Endogenous
Approved drug Yes

Clinical Trials

Phase I 0
Phase II 0
Phase III 0
Approved No

Database connections

Structure pdb 7YS6 7XTB 7XT9 7XTA 7XT8 7E2Y 7WC4 7E32
Ligand site mutations 5-HT1A 5-HT1B 5-HT1D 5-HT2A 5-HT2B 5-HT2C 5-HT4 5-HT5A 5-HT6 5-HT7

Compound is not listed as a drug.

This ligand is endogenous.